Acibadem Adana Hospital

Kuruköprü 01060

1 studies enrolling now · 2 studies all time

What they study most

Advanced Malignancies, Gastroesophageal Junction Adenocarcinoma, Metastatic Gastric Adenocarcinoma

Studies at this site

• A Study to Investigate Tislelizumab Administered as Subcutaneous Injection Versus Intravenous Infusion Plus Chemotherapy in Patients With Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma — Recruiting now
• Study of Tislelizumab, Pamiparib, and Other Investigational Agents in Participants With Advanced Malignancies — Completed